Global Eubiotics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Recent Developments :

• In July 2021, Koninklijke DSM NV (Royal DSM) made headlines with its acquisition of Midori USA Inc., a pioneering start-up focused on developing targeted eubiotics to improve animal health and reduce environmental impact. Midori USA Inc. introduced an innovative technology harnessing glycans sourced from natural food sugars. This breakthrough approach effectively modulates the gut microbiome in animals, ensuring consistent and impactful improvements in gut health. By enhancing nutrient utilization from feed, this advancement promises not only healthier animals but also more sustainable farming practices.

• In 2021, Novus International embarked on a strategic partnership with Agrivida, a leading biotechnology company based in the United States. This collaboration is geared towards fostering research and development initiatives aimed at innovation in eubiotics. By leveraging Agrivida's expertise and technology, Novus International aims to explore novel product developments that can drive its eubiotics business forward, further solidifying its position in the market.

• In 2020, Chr. Hansen Holding AS made waves in the industry with the launch of 'Bovacillus,' a groundbreaking probiotic specifically formulated for dairy and beef cattle. What sets Bovacillus apart is its unique resilience to harsh conditions encountered during feed production, preparation, and within the gastrointestinal tract. This resilience ensures the survival and efficacy of Bacillus spores, leading to improved animal health and performance. Chr. Hansen's introduction of Bovacillus reinforces its commitment to advancing animal health nutrition and positions the company as a key player in the evolving eubiotics landscape.

The global eubiotics market can be segmented based on type, livestock, form, and region, providing insights into the diverse dynamics shaping its growth trajectory. By type, eubiotics are categorized into probiotics, prebiotics, essential oils, organic acids, and others. Probiotics, comprising beneficial live microorganisms, hold a significant share in the market, driven by their role in maintaining gut microbial balance and improving nutrient absorption in animals. Prebiotics, such as fructooligosaccharides and inulin, stimulate the growth of beneficial bacteria in the gut, contributing to enhanced digestive health and immunity. Essential oils and organic acids, derived from plant extracts and microbial fermentation, respectively, are gaining traction as natural alternatives to antibiotic growth promoters, owing to their antimicrobial properties and ability to modulate gut microbiota.

Livestock segmentation encompasses poultry, swine, ruminants, aquaculture, and others, reflecting the diverse applications of eubiotics across animal species. Poultry holds a prominent share in the market, driven by the intensification of poultry production and increasing consumer demand for poultry products. Eubiotics play a crucial role in poultry nutrition, promoting gut health, improving feed efficiency, and reducing the risk of diseases. Similarly, the swine segment is witnessing robust growth, fueled by the adoption of eubiotics to enhance growth performance and mitigate the impact of gastrointestinal disorders. In aquaculture, eubiotics offer solutions for sustainable fish and shrimp production, addressing challenges related to disease management and environmental sustainability. Geographically, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa represent key regions driving market growth, each characterized by unique market dynamics and opportunities.

Global Eubiotics Market Analysis

In this report, the global eubiotics market has been segmented by Type, Animal Type and Geography.

Global Eubiotics Market, Segmentation by Type

The Global Eubiotics Market has been segmented by Type into Probiotics, Prebiotics, Organic Acids and Essential Oils.

The global eubiotics market, segmented by type, offers a nuanced understanding of the diverse array of products driving growth within the industry. Among probiotics, Lactobacilli and Bifidobacteria stand out as key players in promoting gut health and enhancing animal performance. Lactobacilli, known for their ability to produce lactic acid and inhibit the growth of harmful pathogens, are widely used in animal feed formulations to bolster digestive function and strengthen immunity. Similarly, Bifidobacteria, recognized for their role in fermenting dietary fibers and promoting intestinal health, find applications across various livestock species, contributing to improved nutrient absorption and overall well-being. Additionally, other probiotics, including strains such as Enterococcus and Bacillus, are gaining traction for their potential to modulate gut microbiota and confer beneficial effects on animal health.

Prebiotics constitute another significant segment within the eubiotics market, with key players such as inulin, fructo-oligosaccharides (FOS), and galacto-oligosaccharides (GOS) driving market growth. Inulin, a soluble fiber derived from chicory root, serves as a substrate for beneficial bacteria in the gut, promoting their proliferation and enhancing microbial diversity. Fructo-oligosaccharides, naturally occurring carbohydrates found in fruits and vegetables, exert prebiotic effects by selectively stimulating the growth of beneficial bacteria such as Bifidobacteria. Similarly, galacto-oligosaccharides, derived from lactose through enzymatic hydrolysis, exhibit prebiotic properties and contribute to gut health by promoting the growth of lactobacilli and bifidobacteria. Moreover, other prebiotics, such as resistant starches and xylo-oligosaccharides, offer additional avenues for enhancing gut microbiota composition and improving host health outcomes.

Organic acids and essential oils represent another segment of the eubiotics market, offering natural alternatives to conventional antimicrobial agents and growth promoters. Organic acids, including formic acid, acetic acid, and butyric acid, exhibit antimicrobial activity against pathogenic bacteria while supporting the growth of beneficial microbiota in the gut. Essential oils, derived from plant sources such as thyme, oregano, and cinnamon, possess antimicrobial, anti-inflammatory, and antioxidant properties, making them valuable additions to animal feed formulations. These eubiotics contribute to gut health maintenance, immune modulation, and performance enhancement across various livestock species, reflecting the growing trend towards sustainable and natural solutions in animal nutrition.

Global Eubiotics Market, Segmentation by Animal Type

The Global Eubiotics Market has been segmented by Animal Type into Ruminant, Poultry, Swine, Aquaculture and Others.

The global eubiotics market exhibits distinct dynamics across various animal types, catering to the unique nutritional needs and health challenges of each segment. Among these, the ruminant segment commands a notable share, reflecting the significant role of eubiotics in improving digestive efficiency and overall performance in cattle, sheep, and goats. Eubiotics tailored for ruminants often focus on enhancing rumen fermentation, promoting nutrient utilization, and mitigating the risk of metabolic disorders. With the intensification of ruminant production systems and increasing emphasis on sustainable agriculture, the demand for eubiotics in this segment is expected to witness steady growth.

In the poultry segment, eubiotics play a pivotal role in optimizing gut health, feed efficiency, and immune function, thereby enhancing the productivity and profitability of poultry operations. With the rise of intensive poultry farming and growing consumer preference for antibiotic-free poultry products, the demand for eubiotics as alternatives to conventional growth promoters is on the rise. Probiotics and prebiotics are commonly used in poultry nutrition to modulate gut microbiota, reduce the incidence of pathogenic infections, and improve carcass quality, driving market expansion in this segment.

The swine segment represents another significant market opportunity for eubiotics, driven by the need to improve growth performance, feed conversion efficiency, and disease resilience in pigs. Eubiotics offer solutions for enhancing gut health, reducing the reliance on antibiotic growth promoters, and addressing challenges associated with gastrointestinal disorders in swine production. With the tightening regulations on antibiotic usage in pig farming and increasing consumer concerns regarding antimicrobial resistance, the adoption of eubiotics is poised to escalate in the swine industry. Additionally, in the aquaculture segment, eubiotics are gaining traction as sustainable solutions for promoting fish and shrimp health, improving feed conversion ratios, and mitigating the impact of diseases. As the aquaculture sector continues to expand to meet global seafood demand, the incorporation of eubiotics into aquafeed formulations presents opportunities for enhancing production efficiency and environmental sustainability. Lastly, other animal types such as companion animals and exotic species represent niche segments where eubiotics are increasingly being explored for promoting gastrointestinal health, immune function, and overall well-being.

Global Eubiotics Market, Segmentation by Geography

In this report, the Global Eubiotics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Eubiotics Market Share (%), by Geographical Region, 2023

The global eubiotics market exhibits distinctive dynamics across key geographic regions, reflecting varying levels of industrialization, regulatory landscapes, and consumer preferences. In North America, the market is characterized by a strong emphasis on animal health and welfare, coupled with stringent regulations governing antibiotic use in animal feed. The region boasts a mature eubiotics market, driven by advanced research infrastructure, strong industry collaborations, and a growing trend towards natural and sustainable livestock production practices. Additionally, rising consumer awareness regarding the link between diet and health has spurred demand for eubiotics in animal nutrition, particularly in the poultry and swine sectors, where they are utilized to enhance gut health and improve overall performance.

In Europe, the eubiotics market is shaped by stringent regulatory frameworks aimed at reducing antibiotic usage in livestock farming and promoting sustainable agriculture. The region has witnessed a shift towards organic and antibiotic-free animal production systems, driving the adoption of eubiotics as viable alternatives to conventional growth promoters. Moreover, increasing consumer demand for ethically sourced and environmentally friendly food products has fueled the uptake of eubiotics in animal feed formulations. Europe's robust research and innovation ecosystem, coupled with strategic investments in biotechnology and microbiology, continue to drive product development and market expansion across diverse livestock segments.

The Asia Pacific region represents a rapidly growing market for eubiotics, fueled by rising disposable incomes, urbanization, and evolving dietary patterns. In countries such as China and India, escalating demand for high-quality animal protein, coupled with concerns regarding food safety and security, has propelled the adoption of eubiotics in animal feed formulations. Additionally, government initiatives aimed at modernizing livestock production practices and enhancing farm productivity further drive market growth. However, market penetration in the Asia Pacific is challenged by diverse regulatory frameworks, cultural preferences, and the presence of local players offering traditional feed additives. Strategic partnerships, localization strategies, and investments in research and development are key strategies adopted by global eubiotics manufacturers to capitalize on the region's burgeoning market potential.

This report provides an in depth analysis of various factors that impact the dynamics of Global Eubiotics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Rising Concerns about Antibiotic Resistance
• Increasing Demand for Animal Protein
• Emphasis on Performance Enhancement

• Focus on Animal Welfare and Well-being: The focus on animal welfare and well-being represents a significant driver for the global eubiotics market, as consumers and regulatory bodies increasingly prioritize ethical and sustainable practices in livestock production. Eubiotics play a pivotal role in promoting gut health and enhancing the overall well-being of animals, thereby aligning with the principles of humane farming. By optimizing the microbial balance in the gastrointestinal tract, eubiotics contribute to improved digestion, nutrient absorption, and immune function, leading to reduced stress and disease susceptibility in animals. This holistic approach to animal health resonates with consumers seeking products derived from ethically raised and cared-for livestock, driving demand for eubiotics as a preferred alternative to conventional growth promoters and antibiotics.

  The emphasis on animal welfare and well-being is driving innovation and product development within the eubiotics industry, leading to the introduction of novel formulations and delivery mechanisms aimed at enhancing animal comfort and performance. Manufacturers are investing in research and development to identify eubiotic strains and combinations that not only optimize digestive health but also address specific stressors and challenges faced by animals in modern production systems. Furthermore, collaborations between eubiotics producers, animal nutritionists, and veterinarians facilitate the development of tailored solutions that cater to the unique needs of different livestock species and production environments. As consumers continue to demand transparency and accountability in food production, the integration of eubiotics into animal feed formulations serves as a tangible demonstration of the industry's commitment to animal welfare and responsible stewardship of natural resources.

Restraints

• Limited Awareness and Education
• Cost Considerations
• Technical Challenges and Product Quality

• Competition from Alternative Solutions: Competition from alternative solutions represents a significant restraint for the global eubiotics market, as traditional feed additives and emerging technologies vie for market share in addressing animal health and performance. Antibiotic growth promoters (AGPs), although facing regulatory scrutiny, continue to be utilized in some regions, posing a competitive challenge to eubiotics. Despite the documented benefits of eubiotics in promoting gut health and reducing reliance on antibiotics, the entrenched use of AGPs in livestock production systems, coupled with concerns regarding the efficacy and cost-effectiveness of eubiotics, inhibits their widespread adoption.

  The emergence of alternative solutions such as phytogenics, enzymes, and immunomodulators further intensifies competition within the eubiotics market. Phytogenic feed additives derived from plant extracts offer natural alternatives to AGPs and eubiotics, with documented antimicrobial and antioxidant properties. Enzymes play a crucial role in enhancing nutrient utilization and feed efficiency, addressing similar objectives as eubiotics in animal nutrition. Additionally, immunomodulators, including beta-glucans and nucleotides, stimulate immune responses in animals, contributing to overall health and disease resistance. As livestock producers weigh the efficacy, cost, and regulatory considerations of various feed additives, the competition from these alternative solutions poses a challenge for eubiotics manufacturers seeking to differentiate their products and capture market share.

Opportunities

• Regulatory Support and Standards
• Expansion in Emerging Markets
• Expansion into Companion Animal Nutrition

• Integration with Precision Livestock Farming: Integration with precision livestock farming presents a compelling opportunity for the global eubiotics market, as it enables a data-driven approach to animal nutrition and health management. Precision livestock farming leverages advanced technologies such as sensors, data analytics, and automation to monitor key parameters related to animal health, behavior, and performance in real time. By integrating eubiotics into precision livestock farming systems, farmers can optimize feeding strategies and enhance the efficacy of eubiotic interventions. For example, sensors can provide insights into feed intake, digestive efficiency, and gut health parameters, allowing for precise adjustments in eubiotic supplementation to maintain optimal microbial balance and promote animal well-being.

  The convergence of eubiotics with precision livestock farming facilitates personalized nutrition solutions tailored to the specific needs of individual animals or groups. By leveraging data analytics and machine learning algorithms, farmers can analyze vast amounts of data related to animal physiology, environmental conditions, and feed composition to formulate customized eubiotic regimens. This personalized approach maximizes the efficacy of eubiotics in improving animal performance, reducing the incidence of diseases, and minimizing the environmental impact of livestock production. Moreover, integration with precision livestock farming enhances traceability and transparency throughout the supply chain, enabling stakeholders to track the impact of eubiotic interventions on animal health and product quality.

Key players in Global Eubiotics Market include:

• BASF SE
• Cargill Incorporated
• Novozymes
• E. I. du Pont de Nemours and Company
• Kemin Industries Inc
• Lallemand Inc
• Koninklijke DSM NV
• Chr. Hansen Holding AS
• Addcon
• Novus International Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis